ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0809
-0,07%
Bitcoin
69.498,32
0,24%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) News

CRMD

CorMedix (CRMD)

CorMedix Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRMD
DatumZeitQuelleÜberschriftSymbolFirma
06/06/202414h30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants Pass-Through Status to DefencathNASDAQ:CRMDCorMedix Inc
23/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CRMDCorMedix Inc
13/05/202422h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
09/05/202423h06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRMDCorMedix Inc
09/05/202414h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRMDCorMedix Inc
09/05/202413h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/04/202414h30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants TDAPA to DefenCathNASDAQ:CRMDCorMedix Inc
15/04/202414h30GlobeNewswire Inc.CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)NASDAQ:CRMDCorMedix Inc
12/03/202412h30GlobeNewswire Inc.CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
30/01/202423h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
18/01/202422h53Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CRMDCorMedix Inc
18/01/202402h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
18/01/202402h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
18/01/202402h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
18/01/202402h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
15/12/202314h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
14/12/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
14/12/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
21/11/202322h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
16/11/202322h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
14/11/202322h05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
30/10/202321h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
11/10/202314h30GlobeNewswire Inc.CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceNASDAQ:CRMDCorMedix Inc
13/09/202323h26Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CRMDCorMedix Inc
13/09/202323h25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRMDCorMedix Inc
13/09/202323h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRMDCorMedix Inc
08/09/202322h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
08/09/202314h30GlobeNewswire Inc.CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of NephrologyNASDAQ:CRMDCorMedix Inc
30/08/202314h00GlobeNewswire Inc.CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product DefencathNASDAQ:CRMDCorMedix Inc
17/08/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
 Showing the most relevant articles for your search:NASDAQ:CRMD

Kürzlich von Ihnen besucht

PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
TG
ALV
Allianz
NASDAQ
NVDA
NVIDIA
USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
TG
D7G
Nel ASA
FX
EURGBP
Euro vs Sterling
CCOM
US100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten